Patents by Inventor Clas Johansson
Clas Johansson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20240137716Abstract: A device including a prosthesis configured with a sound capture system and configured to evoke a hearing percept based on a captured sound captured by the sound capture system, wherein at least a portion of the prosthesis is configured to attach to a head of a recipient such that sound is captured by the sound capture system externally of the recipient at a location below an ear canal of a human.Type: ApplicationFiled: December 29, 2023Publication date: April 25, 2024Inventors: Marcus VARDFJÄLL, Henrik FYRLUND, Kristian ASNES, Clas JOHANSSON
-
Patent number: 11863940Abstract: A device including a prosthesis configured with a sound capture system and configured to evoke a hearing percept based on a captured sound captured by the sound capture system, wherein at least a portion of the prosthesis is configured to attach to a head of a recipient such that sound is captured by the sound capture system externally of the recipient at a location below an ear canal of a human.Type: GrantFiled: March 16, 2021Date of Patent: January 2, 2024Assignee: Cochlear LimitedInventors: Marcus Vardfjäll, Henrik Fyrlund, Kristian Asnes, Clas Johansson
-
Publication number: 20210211818Abstract: A device including a prosthesis configured with a sound capture system and configured to evoke a hearing percept based on a captured sound captured by the sound capture system, wherein at least a portion of the prosthesis is configured to attach to a head of a recipient such that sound is captured by the sound capture system externally of the recipient at a location below an ear canal of a human.Type: ApplicationFiled: March 16, 2021Publication date: July 8, 2021Inventors: Marcus VARDFJÄLL, Henrik FYRLUND, Kristian ASNES, Clas JOHANSSON
-
Patent number: 10972846Abstract: A device including a prosthesis configured with a sound capture system and configured to evoke a hearing percept based on a captured sound captured by the sound capture system, wherein at least a portion of the prosthesis is configured to attach to a head of a recipient such that sound is captured by the sound capture system externally of the recipient at a location below an ear canal of a human.Type: GrantFiled: April 21, 2017Date of Patent: April 6, 2021Assignee: Cochlear LimitedInventors: Marcus Vardfjäll, Henrik Fyrlund, Kristian Asnes, Clas Johansson
-
Patent number: 10284973Abstract: Presented herein are non-surgical or superficial wearable bands for facilitating hearing. In one embodiment, a wearable band in accordance with embodiments presented herein comprises a frame that is shaped to be positioned around a head of a user. The wearable band further comprises at least one drive plate or adapter configured to be disposed around a section of the frame, wherein the adapter is configured to deliver vibration to the head of the user. A vibration isolation member is disposed between the frame and the adapter. The vibration isolation member is configured to isolate the frame from the vibration at the adapter.Type: GrantFiled: April 3, 2017Date of Patent: May 7, 2019Assignee: Cochlear LimitedInventors: Henrik Fyrlund, Stefan Magnander, Clas Johansson
-
Publication number: 20180288537Abstract: Presented herein are non-surgical or superficial wearable bands for facilitating hearing. In one embodiment, a wearable band in accordance with embodiments presented herein comprises a frame that is shaped to be positioned around a head of a user. The wearable band further comprises at least one drive plate or adapter configured to be disposed around a section of the frame, wherein the adapter is configured to deliver vibration to the head of the user. A vibration isolation member is disposed between the frame and the adapter. The vibration isolation member is configured to isolate the frame from the vibration at the adapter.Type: ApplicationFiled: April 3, 2017Publication date: October 4, 2018Inventors: Henrik Fyrlund, Stefan Magnander, Clas Johansson
-
Publication number: 20170311099Abstract: A device including a prosthesis configured with a sound capture system and configured to evoke a hearing percept based on a captured sound captured by the sound capture system, wherein at least a portion of the prosthesis is configured to attach to a head of a recipient such that sound is captured by the sound capture system externally of the recipient at a location below an ear canal of a human.Type: ApplicationFiled: April 21, 2017Publication date: October 26, 2017Inventors: Marcus VARDFJÄLL, Henrik FYRLUND, Kristian ASNES, Clas JOHANSSON
-
Patent number: 7320872Abstract: The invention relates to an ependymal neural CNS stem cell, which cell expresses the surface protein Notch 1 together with at least one surface protein chosen from the group of Notch 2, Notch 3, CAR (transmembrane protein binding adenovirus) and CFTR cystic fibrosis transmembrane conductance regulator), and which cell also comprises at least one cilium. The invention also relates to preparations, including pharmaceutical preparations, comprising ependymal neural CNS stem cells, in vitro and in vivo assays based thereon and various other uses of the novel ependymal cells according to the invention.Type: GrantFiled: June 27, 2002Date of Patent: January 22, 2008Assignee: NeuroNova ABInventors: Ann Marie Janson, Jonas Frisen, Clas Johansson, Stefan Momma, Diana Clarke, Ming Zhao, Urban Lendahl, Kioumars Delfani
-
Patent number: 7279332Abstract: The present invention relates to a method of determining whether a test compound is a proliferation-inducing or proliferation-inhibiting agent of ependymal neural stem cells. The method comprises: (a) contacting an ependymal neural stem cell with the test compound: and (b) determining the proliferation of the ependymal neural stem cell, wherein if the proliferation of the ependymal neural stem cell is increased in the presence of the test compound as compared to the absence of the test compound, the test compound is identified as a proliferation-inducing agent or wherein if the proliferation of the ependymal neural stem cell is decreased in the presence of the test compound as compared to the absence of the test compound, the test compound is identified as a proliferation-inhibiting agent.Type: GrantFiled: December 20, 2002Date of Patent: October 9, 2007Assignee: NeuroNova ABInventors: Jonas Frisén, Ann Marie Janson, Clas Johansson, Stefan Momma, Diana Clarke, Ming Zhao, Urban Lendahl, Kioumars Delfani
-
Publication number: 20030129747Abstract: The present invention relates to a method of isolating ependymal neural CNS stem cells from a post-natal animal or a human, which method comprises the steps ofType: ApplicationFiled: December 20, 2002Publication date: July 10, 2003Inventors: Jonas Frisen, Ann Marie Janson, Clas Johansson, Stefan Momma, Diana Clarke, Ming Zhao, Urban Lendahl, Kioumars Delfani
-
Publication number: 20030092176Abstract: The invention relates to an ependymal neural CNS stem cell, which cell expresses the surface protein Notch 1 together with at least one surface protein chosen from the group of Notch 2, Notch 3, CAR (transmembrane protein binding adenovirus) and CFTR cystic fibrosis transmembrane conductance regulator), and which cell also comprises at least one cilium. The invention also relates to preparations, including pharmaceutical preparations, comprising ependymal neural CNS stem cells, in vitro and in vivo assays based thereon and various other uses of the novel ependymal cells according to the invention.Type: ApplicationFiled: June 27, 2002Publication date: May 15, 2003Applicant: NeuroNova ABInventors: Ann Marie Janson, Jonas Frisen, Clas Johansson, Stefan Momma, Diana Clarke, Ming Zhao, Urban Lendahl, Kioumars Delfani
-
Patent number: 6541247Abstract: The present invention relates to a method of isolating ependymal neural CNS stem cells from a post-natal animal or a human, which method comprises the steps of (a) screening single cells obtained by dissociating CNS tissue from said animal for cells exhibiting at least one characteristic of an ependymal neural stem cell; and (b) recovering the cells that exhibit the characteristic or characteristics screened for in step (a). The screening may be performed for a specific cell surface protein or by previously labeling the ependymal cells. The invention also relates to isolated ependymal neural CNS stem cells, in vitro and in vivo assays based on the findings according to the invention and various uses of the ependymal neural stem cells according to the invention.Type: GrantFiled: June 25, 1998Date of Patent: April 1, 2003Assignee: Neuronova ABInventors: Jonas Frisën, Ann Marie Janson, Clas Johansson, Stefan Momma, Diana Clarke, Ming Zhao, Urban Lendahl, Kioumars Delfani
-
Patent number: D832812Type: GrantFiled: April 3, 2017Date of Patent: November 6, 2018Assignee: Cochlear LimitedInventors: Henrik Fyrlund, Stefan Magnander, Clas Johansson